Abstract:Abstract Background As an aggressive subtype of breast cancer with a high risk of recurrence, triple-negative breast cancer (TNBC) lacks available treatment targets. LncRNA MIR100HG promotes cell proliferation in TNBC. However, few studies have investigated the molecular mechanism of MIR100HG in TNBC. Thus, additional in-depth investigations are needed to unravel its associated regulatory mechanism. Methods MIR100HG and miR-5590-3p expression in TNBC tissue samples and cell lines was detected by RT-qPCR. Flow cytometry, transwell, wound-healing, CCK8 and colony formation assays were performed to analyse cell apoptosis, cell cycle, invasion, migration and proliferation. The protein expression of orthodenticle homeobox 1 (OTX1) and proteins in the ERK/MAPK signalling pathway were assessed by western blot analysis. Bioinformatics and luciferase assay were performed to predict and validate the interaction between MIR100HG and miR-5590-3p as well as OTX1 and miR-5590-3p. RNA immunoprecipitation (RIP) was used to detect the interaction between MIR100HG and miR-5590-3p. Subcutaneous tumour growth was observed in nude mice. Immunohistochemistry (IHC) analysis was used to assess OTX1 expression in tumour tissues. Results MIR100HG expression was upregulated, whereas that of miR-5590-3p was downregulated in TNBC. MIR100HG was shown to directly interact with miR-5590-3p. Furthermore, MIR100HG knockdown could promote TNBC cell apoptosis and cell cycle arrest in G0/G1 phase while inhibiting migration, invasion and proliferation. Furthermore, miR-5590-3p inhibition showed the opposite results and could reverse the effect of MIR100HG knockdown in TNBC cells. MiR-5590-3p downregulated the ERK/MAPK signalling pathway, suppressed the migration, invasion and proliferation of TNBC cells and promoted their apoptosis and cell cycle arrest in G0/G1 phase by targeting OTX1. In addition, MIR100HG knockdown inhibited OTX1 expression by upregulating miR-5590-3p in vivo, thereby inhibiting tumour growth. Conclusions MIR100HG promotes the progression of TNBC by sponging miR-5590-3p, thereby upregulating OTX1, suggesting a new potential treatment target for TNBC.

MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription

Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer

Mir-532–3P Suppresses Proliferation and Invasion of Ovarian Cancer Cells Via GPNMB/HIF-1α/HK2 Axis

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Mir-638 Suppresses Proliferation by Negatively Regulating High Mobility Group A1 in Ovarian Cancer Cells.

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Mir-603 Targeted Hexokinase-2 to Inhibit the Malignancy of Ovarian Cancer Cells.

Mir-132 Targeting E2F5 Suppresses Cell Proliferation, Invasion, Migration in Ovarian Cancer Cells.

MiR-143-3p Suppresses the Progression of Ovarian Cancer.

Mir-183 Modulated Cell Proliferation and Apoptosis in Ovarian Cancer Through the TGF-β/Smad4 Signaling Pathway

MiR-542-3p, a Microrna Targeting CDK14, Suppresses Cell Proliferation, Invasiveness, and Tumorigenesis of Epithelial Ovarian Cancer

Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene

Mir-532-5p is a Prognostic Marker and Suppresses Cells Proliferation and Invasion by Targeting TWIST1 in Epithelial Ovarian Cancer.

Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis

lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.

Mir-1236-3p Represses The Cell Migration And Invasion Abilities By Targeting Zeb1 In High-Grade Serous Ovarian Carcinoma

Expression and biological function of miR-153 in ovarian cancer

miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.

Mir-215 Functions As a Tumor Suppressor in Epithelial Ovarian Cancer Through Regulation of the X-chromosome-linked Inhibitor of Apoptosis.

Mir-383 Inhibits Ovarian Cancer Cell Proliferation, Invasion and Aerobic Glycolysis by Targeting LDHA

Inhibition of TMEM45A Suppresses Proliferation, Induces Cell Cycle Arrest and Reduces Cell Invasion in Human Ovarian Cancer Cells.